by publisher – Page 6 – Retraction Watch

Sage slaps more than 100 papers from one journal with expressions of concern

The Sage journal American Surgeon has issued a mass expression of concern for 116 articles.

The expression of concern states the journal “was made aware” of “concerning author activity” on the articles.

Sage is no stranger to mass editorial actions. In 2023, the publisher pulled large tranches of papers at least three times, and last year it retracted over 450 papers from a journal the company had acquired from IOS Press. The publisher was one of the first to begin retracting papers in bulk, primarily to combat manipulated peer review.

Elsevier denies AI use in response to evolution journal board resignations

The publisher of the Journal of Human Evolution says it does not use artificial intelligence in its production process, contrary to a statement issued last month by the journal’s editorial board when all but one member of the group resigned.

The statement, shared on X on December 26, noted the journal’s “joint Editors-in-Chief, all Emeritus Editors retired or active in the field, and all but one Associate Editor” were resigning because Elsevier, the journal’s publisher, “has steadily eroded the infrastructure essential to the success of the journal while simultaneously undermining the core principles and practices that have successfully guided the journal for the past 38 years.” Among the examples cited:

Evolution journal editors resign en masse to protest Elsevier changes

All but one member of the editorial board of the Journal of Human Evolution (JHE), an Elsevier title, have resigned, saying the “sustained actions of Elsevier are fundamentally incompatible with the ethos of the journal and preclude maintaining the quality and integrity fundamental to JHE’s success.”

“Elsevier has steadily eroded the infrastructure essential to the success of the journal while simultaneously undermining the core principles and practices that have successfully guided the journal for the past 38 years,” the journal’s “joint Editors-in-Chief, all Emeritus Editors retired or active in the field, and all but one Associate Editor” said in their resignation statement posted to X/Twitter yesterday.

Among other moves, according to the statement, Elsevier “eliminated support for a copy editor and special issues editor,” which they interpreted as saying “editors should not be paying attention to language, grammar, readability, consistency, or accuracy of proper nomenclature or formatting.” The editors say the publisher “frequently introduces errors during production that were not present in the accepted manuscript:”

Finland Publication Forum will downgrade hundreds of Frontiers and MDPI journals

A committee of scholars in Finland has decided to downgrade 271 journals from Frontiers and MDPI in their quality rating system, in a move that may discourage researchers from submitting manuscripts to the outlets.

Both publishers criticized the move, first reported in Times Higher Education, as lacking transparency and seeming to target fully open-access publishers.

Finland’s Publication Forum (JUFO) “is a rating and classification system to support the quality assessment of research output,” which factors into government funding for universities, according to its website. “The objective is to encourage Finnish scholars and researchers to publish their research outcomes in high-level domestic and foreign forums.”

Journal won’t retract paper that involved human organ transplants in China

The Journal of Heart and Lung Transplantation (JHLT) has decided against retracting a November 2024 paper that violated the ethics policy of the publication.

After publishing the paper, which describes a new mechanical circulatory support device used to treat heart failure that was developed in China, staff at the journal realised two of the patients in the study had received organ transplants in that country.

Dozens of research articles have been retracted or flagged for appearing to have used organs procured from executed prisoners in China, and many journals around the world have introduced policies to avoid such research. JHLT’s ethics statement, published in 2022, bans data on human organ transplants from journals or scientific sessions when they originate from countries, particularly China, where organ procurement from prisoners has been observed.

19 months and counting: Former Hindawi journal still hasn’t marked paper

A journal formerly published by Hindawi has yet to publish any sort of notice on a paper sleuths reported for containing duplicated images 1.5 years ago.

According to Kevin Patrick, the sleuth who contacted the publisher in mid-2023, the episode “might be a useful case study” of the issues facing Wiley, which acquired Hindawi in 2021 and stopped using the brand name earlier this year after retracting thousands of papers and closing journals overrun by paper mills.

The article, “Resveratrol Derivative, Trans-3, 5, 4 ′-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation,” appeared in Oxidative Medicine and Cellular Longevity in 2021. Clarivate removed the journal from its Web of Science index in March 2023 for failing to meet quality criteria.

In April 2023, Elisabeth Bik left a comment on PubPeer, noting “several figures in this paper look identical to figures in a 2019 paper by some of the same authors,” which had been retracted. “I could not find wording about e.g. a republication of part of that study, and the 2019 paper is not included in the references,” she wrote.

Wiley medical journal retracts dozens of papers for manipulated peer review, with more to come

International Wound Journal, a Wiley title, has retracted 27 papers since June with notices mentioning “manipulated” or “compromised” peer review.

“A comprehensive investigation examining manipulated peer review in this journal is in progress,” a Wiley spokesperson told Retraction Watch. The publisher anticipates retracting more articles as the investigation continues.

The first retraction of the batch, of the November 2023 article “Analysis of the Association Between Serum Levels of 25(OH)D, Retinol Binding Protein, and Cyclooxygenase-2 and the Disease Severity in Patients with Diabetic Foot Ulcers,” appeared June 14. The notice stated Wiley and the journal’s editor in chief “concluded that the peer review process of this article was manipulated” following an investigation by the publisher.

Crossref suspends company’s membership after Retraction Watch report

Crossref, a nonprofit focused on metadata of scholarly publications, has suspended the membership of a company linked to websites which copied the appearance of journals belonging to Elsevier and Springer Nature, among others from major publishers, Retraction Watch has learned.

The move follows Anna Abalkina’s reporting on Retraction Watch about the activities of Springer Global Publications, which had used its membership in Crossref to assign Digital Object Identifiers (DOIs) to papers in 13 journals with similar names to those established by legitimate publishers. The DOIs linked to papers on webpages mimicking the appearance of the original journals.

Springer Global Publications did not immediately respond to our request for comment on the suspension of its Crossref membership. The company previously told us it did not “create, review, or manage the content associated with the identifiers we issue,” and did not publish any journals.

The website of the company has also been suspended by its hosting provider, and is no longer available online.

Company linked to cloned journals of major publishers denies cloning journals of major publishers

After we reported on a new scam to publish papers on webpages remarkably similar to those of Elsevier, Springer, the American Medical Association and other major publishers, the company linked to the clones denied any role in producing the content they contain.

Until we reached out for comment, the company “Springer Global Publication” – which is not affiliated with Springer Nature – had advertised a variety of services on its website, including finding a writer for research papers, editing manuscripts, developing research proposals, analyzing data and managing the peer review process, a collection of services which is a classic attribute of a paper mill. After we emailed them, they removed descriptions of these services from their website, as well as links to papers published in cloned journals, but did not respond before publication of our story.

After our story appeared, we received an email signed by “Administrator – Springergloballtd.com,” in which the company said it did not “create, review, or manage the content associated with the identifiers we issue.”

The company stated:

Exclusive: New hijacking scam targets Elsevier, Springer Nature, and other major publishers

Until recently, journal hijackers do not appear to have targeted titles from big publishers, in part because their well-known website designs made such clones easy to detect.

Typically, cloned versions of journals’ websites are of low quality and don’t resemble the recognizable and professional designs of Springer Nature and Elsevier. As described in previous posts, fraudulent publishers would usually copy the ISSN, title and other metadata of niche and university journals in order to avoid identification, and possibly index their unauthorized content in bibliographic databases such as Scopus or Web of Science.

We’ve cataloged over 300 such cloned journals in the Retraction Watch Hijacked Journal Checker, a small number of which involve major publishers like Springer Nature, Elsevier and Wiley. For example, earlier this year the Journal of Academic Ethics and Machine Intelligence Research, both published by Springer Nature, were cloned.

But earlier this month, William Black, founder and CEO of PSIref, an online platform aggregating scholarly publication data which offers advertising opportunities for publishers, sent me evidence of a new, more sophisticated scam.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: